Aridis Pharmaceuticals Inc.
ARDS
|
|
| |
|
| Trading Volume | 33,389,508 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 13.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | -73.4% | -24.5% |
| Q2 | - | - | -29.9% | -37.5% |
| Q3 | - | - | 40.9% | -15.5% |
| Q4 | - | - | - | 26.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| -43.2 | -15.8 | -44.3 | -42.7 | 120.6 | -44.6 | 40.9 | - | - | - | - | - |
| 2022 | |||||||||||
| -22.3 | 10.5 | -12 | -29 | -8 | -4.4 | 102.7 | -34.5 | -36.3 | 11.8 | -12.5 | 29.7 |
| 2021 | |||||||||||
| 15.7 | -8.1 | -8.5 | 3.2 | -5.1 | 28 | -32.6 | -19.4 | -8.5 | -4.9 | -35.4 | 3.1 |
| 2020 | |||||||||||
| 48.4 | -3.6 | -14.4 | 10.9 | 8.5 | -4.5 | 5.6 | - | -3.4 | -4.6 | 6.7 | -11.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.4 | -0.8 | -0.7 |
| Q2 | 0.3 | -0.5 | -0.5 | -0.5 |
| Q3 | 0 | -0.5 | -1.9 | -0.7 |
| Q4 | 0 | -0.3 | -0.6 | -2.4 |
| A | 0.11 | -1.62 | -3.8 | -2.4 |